<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2176</journal-id>
<journal-title><![CDATA[Revista Cubana de Oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Oftalmol]]></abbrev-journal-title>
<issn>0864-2176</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21762019000100013</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Midriáticos intracamerales en la cirugía de catarata]]></article-title>
<article-title xml:lang="en"><![CDATA[Intracameral mydriatics in cataract surgery]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cuan Aguilar]]></surname>
<given-names><![CDATA[Yoriel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Montero Díaz]]></surname>
<given-names><![CDATA[Eric]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Álvarez Martínez]]></surname>
<given-names><![CDATA[Judith]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Candelaria]]></surname>
<given-names><![CDATA[Eneida]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cárdenas Díaz]]></surname>
<given-names><![CDATA[Taimi]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hormigó Puertas]]></surname>
<given-names><![CDATA[Iraisi F.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto cubano de Oftalmología &#8220;Ramón Pando Ferrer&#8221;  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Policlínico Universitario &#8220;Felipe I. Rodríguez Ramos&#8221;  ]]></institution>
<addr-line><![CDATA[San Antonio de los Baños ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<volume>32</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21762019000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21762019000100013&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21762019000100013&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Durante la cirugía de catarata, la inducción de la dilatación de la pupila (midriasis) y el mantenimiento de un grado adecuado de esta a lo largo de toda la operación son elementos críticos para la eliminación y el reemplazo exitoso del cristalino. Una pupila pequeña o un cierre pupilar durante la cirugía hacen que esta sea un desafío desde el punto de vista técnico y aumente el riesgo de complicaciones transquirúrgicas, por lo que una midriasis adecuada y mantenida ha permanecido hasta nuestros días como un pilar fundamental para maximizar la seguridad y los resultados refractivos de la cirugía de catarata moderna. Esta midriasis se consigue habitualmente con la aplicación previa de colirios anticolinérgicos y simpaticomiméticos, con los cuales el tiempo de espera para la dilatación pupilar es frecuentemente más largo que el procedimiento quirúrgico; tienen una significativa absorción sistémica que pueden aumentar el riesgo de efectos secundarios cardiovasculares, y el efecto midriático tiende a desaparecer durante la cirugía. Con el objetivo de acceder a la información actualizada sobre los fármacos midriáticos más usados de modo intracameral, sus dosis y formas de aplicación durante la cirugía de catarata, se realiza el presente trabajo de revisión.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT In cataract surgery, induction and maintenance of an adequate degree of pupil dilation (mydriasis) throughout the operation are critical elements for the successful removal and replacement of the crystalline lens. A small pupil or pupil closure during surgery pose a technical challenge and increase the risk of intraoperative complications. This is the reason why adequate, maintained mydriasis has remained to this day a fundamental pillar to maximize both safety and satisfactory refractive results in modern cataract surgery. Mydriasis is normally achieved with the previous application of anticholinergic and sympathomimetic eye drops, for which the waiting time for pupil dilation is often longer than the surgical procedure, they have significant systemic absorption which may increase the risk of cardiovascular side effects, and the mydriatic effect tends to vanish during surgery. A bibliographic review was conducted with the purpose of accessing updated information about the most commonly used intracameral mydriatic drugs, their doses and modes of application during cataract surgery.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Midriasis]]></kwd>
<kwd lng="es"><![CDATA[midriáticos]]></kwd>
<kwd lng="es"><![CDATA[intracameral]]></kwd>
<kwd lng="es"><![CDATA[intraoperatorio]]></kwd>
<kwd lng="es"><![CDATA[cirugía de catarata]]></kwd>
<kwd lng="en"><![CDATA[Mydriasis]]></kwd>
<kwd lng="en"><![CDATA[mydriatics]]></kwd>
<kwd lng="en"><![CDATA[intracameral]]></kwd>
<kwd lng="en"><![CDATA[intraoperative]]></kwd>
<kwd lng="en"><![CDATA[cataract surgery]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lawuyi]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Gurbaxani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgery]]></article-title>
<source><![CDATA[Clin Ophthalmol]]></source>
<year>2015</year>
<volume>9</volume>
<page-range>1249-54</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davey]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Purslow]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Clay]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vataire]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Budget impact model of Mydrane(r), a new intracameral injectable used for intraoperative mydriasis, from a UK hospital perspective]]></article-title>
<source><![CDATA[BMC Ophthalmology]]></source>
<year>2018</year>
<volume>18</volume>
<page-range>104</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hashemi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Seyedian]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Mohammadpour]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Small pupil and cataract surgery]]></article-title>
<source><![CDATA[Curr Opin Ophthalmol]]></source>
<year>2015</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guzek]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Holm]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cotter]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk factors for intraoperative complications in 1,000 extracapsular cataract cases]]></article-title>
<source><![CDATA[Ophthalmology]]></source>
<year>1987</year>
<volume>94</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>461-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ajay]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Saranya]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sundaresh]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Hithashree]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
<name>
<surname><![CDATA[Hemalatha]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
<name>
<surname><![CDATA[Krishnaswamy]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy and safety of intraoperative intracameral mydriasis in manual small incision cataract surgery - A randomized controlled trial]]></article-title>
<source><![CDATA[Indian J Ophthalmol]]></source>
<year>2017</year>
<volume>65</volume>
<page-range>584-8</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sathish Srinivasan]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracameral mydriatics during cataract surgery]]></article-title>
<source><![CDATA[J Cataract Refract Surg]]></source>
<year>2018</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>257-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arshinoff]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Opalinski]]></surname>
<given-names><![CDATA[YAV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The pharmacotherapy of cataract surgery]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Yanoff]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Duker]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
</person-group>
<source><![CDATA[Ophthalmology]]></source>
<year>2008</year>
<page-range>434-40</page-range><publisher-loc><![CDATA[St Louis (M O) ]]></publisher-loc>
<publisher-name><![CDATA[Mosby Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cortés]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cuesta]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Capítulo 32.Fármacos midriáticos: pautas de dilatación en cirugía de cristalino]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Lorente]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mendicute]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Cirugía del cristalino: LXXXIV ponencia oficial de la Sociedad Española de Oftalmología, 2008]]></source>
<year>2008</year>
<page-range>421-7</page-range><publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Sociedad Española de Oftalmología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez-Rementería]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Midriáticos intracamerulares durante la facoemulsificación]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Lorente]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mendicute]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Cirugía del cristalino: LXXXIV ponencia oficial de la Sociedad Española de Oftalmología, 2008]]></source>
<year>2008</year>
<page-range>464-70</page-range><publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Sociedad Española de Oftalmología]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<collab>Rajesh Subhash Joshi</collab>
<article-title xml:lang=""><![CDATA[Phacoemulsification without preoperative mydriasis in patients with age-related cataract associated with type 2 diabetes]]></article-title>
<source><![CDATA[Clin Ophthalmol]]></source>
<year>2016</year>
<volume>10</volume>
<page-range>2427-32</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intraoperative floppy iris syndrome associated with tamsulosin]]></article-title>
<source><![CDATA[J Cataract Refract Surg]]></source>
<year>2005</year>
<volume>31</volume>
<page-range>664-73</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lundberg]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Behndig]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracameral mydriatics in phacoemulsification cataract surgery]]></article-title>
<source><![CDATA[J Cataract Refract Surg]]></source>
<year>2003</year>
<volume>29</volume>
<page-range>2366-71</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lundberg]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[J Cataract Refract]]></article-title>
<collab>Behndig A Separate and additive mydriatic effects of lidocaine hydrochloride.phenylephrine.and cyclopentolate after intracameral injection</collab>
<source><![CDATA[Surg]]></source>
<year>2008</year>
<volume>34</volume>
<page-range>280-3</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nikeghbali]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Falavarjani]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Kheirkhah]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pupil dilation with intracameral lidocaine during phacoemulsification benefits for the patient and surgeon]]></article-title>
<source><![CDATA[Indian J Ophthalmol]]></source>
<year>2008</year>
<volume>56</volume>
<page-range>63-4</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Shugar]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optimizing the intracameral dilation regimen for cataract surgery prospective randomized comparison of 2 solutions]]></article-title>
<source><![CDATA[J Cataract Refract Surg]]></source>
<year>2009</year>
<volume>35</volume>
<page-range>273-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Labetoulle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the efficacy and safety of a standardised intracameral combination of mydriatics and anaesthetics for cataract surgery]]></article-title>
<source><![CDATA[Br J Ophthalmol]]></source>
<year>2016</year>
<volume>100</volume>
<page-range>976-85</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gunnie Backstrom]]></surname>
</name>
<name>
<surname><![CDATA[Anders Behndig]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Redilatation with intracameral mydriatics in phacoemulsification surgery]]></article-title>
<source><![CDATA[Acta Ophthalmol Scand]]></source>
<year>2006</year>
<volume>84</volume>
<page-range>100-4</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gurbaxani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Packard]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin]]></article-title>
<source><![CDATA[Eye]]></source>
<year>2007</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>331-2</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lorente]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracameral phenylephrine 1,5 % for prophylaxis against intraoperative floppy iris syndrome prospective, randomized fellow eye study]]></article-title>
<source><![CDATA[Ophthalmology]]></source>
<year>2012</year>
<volume>119</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2053-8</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Radwan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kadare]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The short to medium-term risks of intracameral phenylephrine]]></article-title>
<source><![CDATA[Middle East Afr J Ophthalmol]]></source>
<year>2012</year>
<volume>19</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>357-60</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cionni]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Barros]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Kaufman]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Osher]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cataract surgery without preoperative eyedrops]]></article-title>
<source><![CDATA[J Cataract Refract Surg]]></source>
<year>2003</year>
<volume>29</volume>
<page-range>2281-3</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benatar-Haserfaty]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Facoemulsificación sin midriasis preoperatoria beneficios para el paciente]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Álvarez de Rementería-Fernández]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Muriel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch Soc Esp Oftalmol]]></source>
<year>2004</year>
<volume>79</volume>
<page-range>53-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<collab>American Society of Cataract and Refractive Surgery</collab>
<source><![CDATA[Alerta Clínica en Estados Unidos: uso de epinefrina para mantener la midriasis durante la cirugía de cataratas]]></source>
<year>2017</year>
<publisher-name><![CDATA[News room]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grob]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[González-González]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Daly]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of mydriasis and pain in cataract and intraocular lens surgery review of current medications and future directions]]></article-title>
<source><![CDATA[Clin Ophthalmol]]></source>
<year>2014</year>
<volume>8</volume>
<page-range>1281-9</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoffman]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Braga-Mele]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Donaldson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cataract surgery and nonsteroidal antinflammatory drugs]]></article-title>
<source><![CDATA[J Cataract Refract Surg]]></source>
<year>2016</year>
<volume>42</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1368-79</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Won Jung]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hoon Chung]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kweon Kim]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Yul Seo]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effects of two non-steroidal antinflammatory drugs, bromfenac 0 1 % and ketorolac 0.45 % on cataract surgery]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[Tae-im]]></given-names>
</name>
</person-group>
<source><![CDATA[Yonsei Med J]]></source>
<year>2015</year>
<volume>56</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1671-7</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiambaretta]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pupil dilation dynamics with an intracameral fixed combination of mydriatics and anesthetic during cataract surgery]]></article-title>
<source><![CDATA[J Cataract Refract Surg]]></source>
<year>2018</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>341-7</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hovanesian]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain integrated results from 2 pivotal phase 3 studies]]></article-title>
<source><![CDATA[J Cataract Refract Surg]]></source>
<year>2015</year>
<volume>41</volume>
<page-range>2060-8</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Visual outcomes, efficacy and surgical complications associated with intracameral phenylephrine 1 0 %/ ketorolac 0.3 % administered during cataract surgery]]></article-title>
<source><![CDATA[Clin Ophthalmol]]></source>
<year>2018</year>
<volume>12</volume>
<page-range>21-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
